輔助生殖技術市場規模、佔有率及成長分析（按類型、最終用途和地區）－2025-2032 年產業預測

Assisted Reproductive Technology Market Size, Share, and Growth Analysis, By Type (In-Vitro Fertilization (IVF), Artificial Insemination), By End-Use (Fertility Clinics, Hospitals), By Region - Industry Forecast 2025-2032

出版日期: 2025年04月01日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

輔助生殖技術市場規模預計到 2023 年將達到 359.2 億美元，從 2024 年的 389 億美元成長到 2032 年的 736.2 億美元，預測期內（2025-2032 年）的複合年成長率為 8.3%。

由於不孕不育率上升以及人們對生育治療和代孕的認知不斷提高，全球輔助生殖技術 (ART) 市場正在經歷顯著成長。 ART 涵蓋一系列方法，包括體外受精 (IVF) 和懷孕代孕，旨在幫助個人和夫婦懷孕。世界衛生組織 (WHO) 估計，2020 年將有約 4,800 萬對夫婦和 1.86 億個人面臨不孕不育的診斷，這凸顯了對此類服務的巨大需求。此外，美國疾病管制與預防中心強調，6% 至 12% 的美國多囊性卵巢症候群女性也患有不孕症，這進一步推動了需求。在公共和私營部門的資金支持以及技術的不斷進步下，ART 市場的未來仍然強勁。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Merck KGaA（Germany）
Cook Medical（USA）
Vitrolife AB（Sweden）
CooperSurgical, Inc.（USA）
Irvine Scientific（USA）
Ferring Pharmaceuticals（Switzerland）
Genea Limited（Australia）
Cryolab Ltd.（UK）
Bloom IVF Center（India）
Cosmos Biomedical Ltd.（UK）
European Sperm Bank（Denmark）
Parallabs（UK）
Microm UK Ltd.（UK）
Esco Medical（Singapore）
IVFtech ApS（Denmark）
The Cooper Companies, Inc.（USA）
Thermo Fisher Scientific Inc.（USA）

結論和建議

簡介目錄

Product Code: SQMIG35G2228

Assisted Reproductive Technology Market size was valued at USD 35.92 billion in 2023 and is poised to grow from USD 38.9 billion in 2024 to USD 73.62 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The global market for Assisted Reproductive Technology (ART) is experiencing significant growth due to rising infertility rates and increased awareness of fertility treatments and surrogacy. ART encompasses a range of methods including in vitro fertilization (IVF) and gestational surrogacy, designed to assist individuals and couples in conceiving. The World Health Organization estimates that in 2020, approximately 48 million couples and 186 million individuals faced infertility diagnoses, emphasizing the scale of the need for these services. Additionally, the Centers for Disease Control and Prevention highlight that 6% to 12% of American women with PCOS also struggle with infertility, further propelling demand. With funding from both public and private sectors and ongoing technological advancements, the ART market's prospects remain robust.

Top-down and bottom-up approaches were used to estimate and validate the size of the Assisted Reproductive Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Assisted Reproductive Technology Market Segments Analysis

Global Assisted Reproductive Technology Market is segmented by Type, End-Use and region. Based on Type, the market is segmented into In-Vitro Fertilization (IVF), Artificial Insemination and Others. Based on End-Use, the market is segmented into Fertility Clinics, Hospitals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Assisted Reproductive Technology Market

The rise in infertility rates, driven by factors like delayed childbirth, lifestyle modifications, and environmental influences, underscores the growing importance of Assisted Reproductive Technology (ART). As more couples seek solutions for their infertility issues, there is a corresponding increase in demand for ART services. This heightened interest not only highlights the need for viable reproductive options but also propels the growth of the ART industry, making it a vital component of modern reproductive health solutions. Consequently, the trend indicates a significant expansion potential for ART, reflecting society's evolving approach to family building in the face of fertility challenges.

Restraints in the Assisted Reproductive Technology Market

One of the primary challenges facing the Assisted Reproductive Technology (ART) market is the high cost associated with treatments such as in vitro fertilization (IVF) and other related procedures. These substantial expenses can limit accessibility and affordability for many patients, ultimately hindering the overall growth of the market, especially in areas that lack robust healthcare infrastructure. As a result, the financial burden can prevent individuals from seeking necessary ART services, thereby stifling market expansion in regions where the demand for such technologies exists but is unmet due to prohibitive costs.

Market Trends of the Assisted Reproductive Technology Market

The Assisted Reproductive Technology (ART) market is witnessing a significant trend towards the expansion of personalized solutions, bolstered by advancements in genetic screening and embryo analysis. This shift towards individualized ART therapies is driven by the desire to enhance overall success rates and optimize treatment efficiency. By addressing specific causes of infertility and tailoring approaches to meet individual patient needs, healthcare providers can offer more targeted and effective fertility treatments. As a result, this trend not only improves patient outcomes but also fosters continued innovation in the reproductive health sector, reflecting an evolving landscape that prioritizes personalized care.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Advancement

Global Assisted Reproductive Technology Market Size by Type & CAGR (2025-2032)

Market Overview
In-Vitro Fertilization (IVF)
Artificial Insemination
Others

Global Assisted Reproductive Technology Market Size by End-Use & CAGR (2025-2032)

Market Overview
Fertility Clinics
Hospitals
Others

Global Assisted Reproductive Technology Market Size & CAGR (2025-2032)

North America (Type, End-Use)
- US
- Canada
Europe (Type, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitrolife AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Irvine Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genea Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cryolab Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bloom IVF Center (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cosmos Biomedical Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
European Sperm Bank (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parallabs (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microm UK Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Esco Medical (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IVFtech ApS (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Cooper Companies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments